Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Melatonin improved mental health and metabolism in women with PCOS.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Early diagnosis and treatment of TPP can prevent complications.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

The ITGB6 gene is important for tissue repair and hair growth, and mutations can lead to enamel defects and other health issues.

New compounds may soon be tested to treat excessive hair growth in women.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.